Mustang Bio, Inc.
MBIO
$0.61
-$0.02-3.31%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -538.00K | -468.00K | -762.00K | -153.00K | -952.00K |
| Total Depreciation and Amortization | 0.00 | 0.00 | 0.00 | 41.00K | 75.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -435.00K | -375.00K | -751.00K | -140.00K | 1.05M |
| Change in Net Operating Assets | -745.00K | 25.00K | 174.00K | -1.14M | -2.17M |
| Cash from Operations | -1.72M | -818.00K | -1.34M | -1.39M | -2.00M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | 0.00 | 0.00 | 0.00 | 1.17M | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 0.00 | 0.00 | 0.00 | 1.17M | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00 | 7.15M | -- | 7.62M | 4.94M |
| Repurchase of Common Stock | -- | -- | -235.00K | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 0.00 | 7.15M | -235.00K | 7.62M | 4.94M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.72M | 6.33M | -1.57M | 7.39M | 2.94M |